EQ vs PSA · rev $41.1M vs rev $4.82B
Equillium Inc (EQ) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Equillium Inc (EQ) is a biotechnology company listed on NASDAQ.
PSA (PSA) common stock.
Latest reported EQ revenue for 2024-12-31 was $41.1M. Net income was -$8.1M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. EQ currently screens at market cap $189.0M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
EQ currently screens at market cap $189.0M. PSA currently screens at market cap $0.
Not investment advice. Open the EQ and PSA stock pages for the full models.
Not investment advice.